Kinetic analysis of the interactions between vaccinia virus complement control protein and human complement proteins C3b and C4b

Journal of Virology

Volumn 78, Issue 17, 2004, Pages 9446-9457

  Bernet, John ^a   Mullick, Jayati ^a   Panse, Yogesh ^a   Parab, Pradeep B ^a   Sahu, Arvind ^a  

^a NATIONAL CENTRE FOR CELL SCIENCE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C4B; UNCLASSIFIED DRUG; VACCINIA VIRUS COMPLEMENT CONTROL PROTEIN; VIRUS PROTEIN;

ARTICLE; BINDING KINETICS; COMPLEMENT SYSTEM; HUMAN; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SURFACE PLASMON RESONANCE; VACCINIA VIRUS; VIRUS INFECTION; WESTERN BLOTTING;

BINDING SITES; COMPLEMENT C3B; COMPLEMENT C4B; ELECTRON SPIN RESONANCE SPECTROSCOPY; HUMANS; KINETICS; PROTEIN BINDING; SODIUM CHLORIDE; VACCINIA VIRUS; VIRAL PROTEINS;

EID: 4143153933     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.17.9446-9457.2004     Document Type: Article

References (55)

1. Ahearn, J. M., M. B. Fischer, D. Croix, S. Goerg, M. Ma, J. Xia, X. Zhou, R. G. Howard, T. L. Rothstein, and M. C. Carroll. 1996. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B-cell response to T-dependent antigen. Immunity 4:251-262.
2. Alcami, A., and U. H. Koszinowski. 2000. Viral mechanisms of immune evasion. Trends Microbiol. 8:410-418.
3. Alsenz, J., J. D. Lambris, T. F. Schulz, and M. P. Dierich. 1984. Localization of the complement-component-C3b-binding site and the cofactor activity for factor I in the 38-kDa tryptic fragment of factor H. Biochem. J. 224:389-398.
4. Arnaout, M. A., N. Dana, J. Melamed, R. Medicus, and H. R. Colten. 1983. Low ionic strength or chemical cross-linking of monomeric C3b increases its binding affinity to the human complement C3b receptor. Immunology 48:229-237.
5. Bernet, J., J. Mullick, A. K. Singh, and A. Sahn. 2003. Viral mimicry of the complement system. J. Biosci. 28:249-264.
6. Blom, A. M., J. Webb, B. O. Villoutreix, and B. Dahlback. 1999. A cluster of positively charged amino acids in the C4BP alpha-chain is crucial for C4b binding and factor I cofactor function. J. Biol. Chem. 274:19237-19245.
7. Carroll, M. C., and D. T. Fearon. 2004. Regulation by complement of acquired immunity, p. 327-333. In J. E. Volanakis and M. M. Frank (ed.), The human complement system in health and disease. Marcel Dekker, Inc., New York, N.Y.
8. Clemenza, L., and D. E. Isenman. 2004. The C4A and C4B isotypic forms of human complement fragment C4b have the same intrinsic affinity for complement receptor 1 (CR1/CD35). J. Immunol. 172:1670-1680.
9. Cooper, N. R. 1998. Complement and viruses, p. 393-407. In J. E. Volanakis and M. M. Frank (ed.), The human complement system in health and disease. Marcel Dekker, Inc., New York, N.Y.
10. Da Costa, X. J., M. A. Brockman, E. Alicot, M. Ma, M. B. Fischer, X. Zhou, D. M. Knipe, and M. C. Carroll. 1999. Humoral response to herpes simplex virus is complement-dependent. Proc. Natl. Acad. Sci. USA 96:12708-12712.
11. DiScipio, R. G. 1981. The binding of human complement proteins CS, factor B, β1H and properdin to complement fragment C3b on zymosan. Biochem. J. 199:485-496.
12. Fischer, M. B., M. Ma, S. Goerg, X. Zhou, J. Xia, O. Finco, S. Han, G. Kelsoe, R. G. Howard, T. L. Rothstein, E. Kremmer, F. S. Rosen, and M. C. Carroll. 1996. Regulation of the B-cell response to T-dependent antigens by classical pathway complement. J. Immunol. 157:549-556.
13. Gewurz, B. E., R. Gaudet, D. Tortorella, E. W. Wang, and H. L. Ploegh. 2001. Virus subversion of immunity: a structural perspective. Curr. Opin. Immunol. 13:442-450.
14. Hebell, T., J. M. Ahearn, and D. T. Fearon. 1991. Suppression of the immune response by a soluble complement receptor of B lymphocytes. Science 254:102-105.
15. Henderson, C. E., K. Bromek, N. P. Mullin, B. O. Smith, D. Uhrin, and P. N. Barlow. 2001. Solution structure and dynamics of the central CCP module pair of a poxvirus complement control protein. J. Mol. Biol. 307:323-339.
16. Heyman, B., E. J. Wiersma, and T. Kinoshita. 1990. In vivo inhibition of the antibody response by a complement receptor-specific monoclonal antibody. J. Exp. Med. 172:665-668.
17. Isaacs, S. N., G. J. Kotwal, and B. Moss. 1992. Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence. Proc. Natl. Acad. Sci. USA 89:628-632.
18. Johnston, J. B., and G. McFadden. 2003. Poxvirus immunomodulatory strategies: current perspectives. J. Virol. 77:6093-6100.
19. Jokiranta, T. S., J. Hellwage, V. Koistinen, P. F. Zipfel, and S. Meri. 2000. Each of the three binding sites on complement factor H interacts with a distinct site on C3b. J. Biol. Chem. 275:27657-27662.
20. Klickstein, L. B., T. J. Bartow, V. Miletic, L. D. Rabson, J. A. Smith, and D. T. Fearon. 1988. Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis. J. Exp. Med. 168:1699-1717.
21. Kostavasili, I., A. Sahu, H. M. Friedman, R. J. Eisenberg, G. H. Cohen, and J. D. Lambris. 1997. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus. J. Immunol. 158:1763-1771.
22. Kotwal, G. J. 1994. Purification of virokines using ultrafiltration. Am. Biotechnol. Lab. 12:76-77.
23. Kotwal, G. J., S. N. Isaacs, R. Mckenzie, M. M. Frank, and B. Moss. 1990. Inhibition of the complement cascade by the major secretory protein of vaccinia virus. Science 250:827-830.
24. Kotwal, G. J., and B. Moss. 1988. Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins. Nature 335:176-178.
25. Krych, M., R. Hauhart, and J. P. Atkinson. 1998. Structure-function analysis of the active sites of complement receptor type 1. J. Biol. Chem. 273:8623-8629.
26. Krych, M., D. Hourcade, and J. P. Atkinson. 1991. Sites within the complement C3b C4b receptor important for the specificity of ligand binding. Proc. Natl. Acad. Sci. USA 88:4353-4357.
27. Lachmann, P. J. 2002. Microbial subversion of the immune response. Proc. Natl. Acad. Sci. USA 99:8461-8462.
28. Lambris, J. D., A. Sahu, and R. Wetsel. 1998. The chemistry and biology of C3, C4, and CS, p. 83-118. In J. E. Volanakis and M. Frank (ed.), The human complement system in health and disease. Marcel Dekker, Inc., New York, N.Y.
29. Lee, S. H., J. U. Jung, and R. E. Means. 2003. "Complementing" viral infection: mechanisms for evading innate immunity. Trends Microbiol. 11:449-452.
30. Liszewski, M. K., M. Leung, W. Cui, V. B. Subramanian, J. Parkinson, P. N. Barlow, M. Manchester, and J. P. Atkinson. 2000. Dissecting sites important for complement regulatory activity in membrane cofactor protein (MCP; CD46). J. Biol. Chem. 275:37692-37701.
31. Lubinski, J., T. Nagashunmugam, and H. M. Friedman. 1998. Viral interference with antibody and complement. Semin. Cell Dev. Biol. 9:329-337.
32. Mckenzie, R., G. J. Kotwal, B. Moss, C. H. Hammer, and M. M. Frank. 1992. Regulation of complement activity by vaccinia virus complement-control protein. J. Infect. Dis. 166:1245-1250.
33. Means, R. E., S. M. Lang, Y. H. Chung, and J. U. Jung. 2002. Kaposi's sarcoma associated herpesvirus immune evasion strategies. Front Biosci. 7:e185-e203.
34. Molina, H., V. M. Holers, B. Li, Y. Fung, S. Mariathasan, J. Goellner, J. Strauss-Schoenberger, R. W. Karr, and D. D. Chaplin. 1996. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc. Natl. Acad. Sci. USA 93:3357-3361.
35. Morton, T. A., D. B. Bennett, E. R. Appelbaum, D. M. Cusimano, K. O. Johanson, R. E. Matico, P. R. Young, M. Doyle, and I. M. Chaiken. 1994. Analysis of the interaction between human interleukin-5 and the soluble domain of its receptor using a surface plasmon resonance biosensor. J. Mol. Recognit. 7:47-55.
36. Moss, B. 2001. Poxviridae: the viruses and their replication, p. 2849-2883. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 4th ed. Lippincott/The Williams & Wilkins Co., Philadelphia, Pa.
37. Mullick, J., J. Bernet, A. K. Singh, J. D. Lambris, and A. Sahu. 2003. Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) open reading frame 4 protein (kaposica) is a functional homolog of complement control proteins. J. Virol. 77:3878-3881.
38. Mullick, J., A. Kadam, and A. Sahu. 2003. Herpes and pox viral complement control proteins: "the mask of self." Trends Immunol. 24:500-507.
39. Murthy, K. H., S. A. Smith, V. K. Ganesh, K. W. Judge, N. Mullin, P. N. Barlow, C. M. Ogata, and G. J. Kotwal. 2001. Crystal structure of a complement control protein that regulates both pathways of complement activation and binds heparan sulfate proteoglycans. Cell 104:301-311.
40. Oran, A. E., and D. E. Isenman. 1999. Identification of residues within the 727-767 segment of human complement component C3 important for its interaction with factor H and with complement receptor 1 (CR1, CD35). J. Biol. Chem. 274:5120-5130.
41. Rosengard, A. M., L. C. Alonso, L. C. Korb, W. M. Baldwin, III, F. Sanfilippo, L. A. Turka, and J. M. Ahearn. 1999. Functional characterization of soluble and membrane-bound forms of vaccinia virus complement control protein (VCP). Mol. Immunol. 36:685-697.
42. 1 inactivates the alternative complement pathway. J. Immunol. 160:5596-5604.
43. Sahu, A., and J. D. Lambris. 2001. Structure and biology of complement protein C3, a connecting link between innate and acquired immunity. Immunol. Rev. 180:35-48.
44. Sahu, A., A. M. Soulika, D. Morikis, L. Spruce, W. T. Moore, and J. D. Lambris. 2000. Binding kinetics, structure-activity relationship, and biotransformation of the complement inhibitor compstatin. J. Immunol. 165:2491-2499.
45. Sarrias, M. R., S. Franchini, G. Canziani, E. Argyropoulos, W. T. Moore, A. Sahu, and J. D. Lambris. 2001. Kinetic analysis of the interactions of complement receptor 2 (CR2, CD21) with its ligands C3d, iC3b, and the EBV glycoprotein gp350/220. J. Immunol. 167:1490-1499.
46. Sect, B. T., J. B. Johnston, C. R. Brunetti, J. W. Barrett, H. Everett, C. Cameron, J. Sypula, S. H. Nazarian, A. Lucas, and G. McFadden. 2003. Poxviruses and immune evasion. Annu. Rev. Immunol. 21:377-423.
47. Seya, T., K. Nakamura, T. Masaki, C. Ichihara-Itoh, M. Matsumoto, and S. Nagasawa. 1995. Human factor H and C4b-binding protein serve as factor I-cofactors both encompassing inactivation of C3b and C4b. Mol. Immunol. 32:355-360.
48. Sharma, A. K., and M. K. Pangburn. 1996. Identification of three physically and functionally distinct binding sites for C3b in human complement factor H by deletion mutagenesis. Proc. Natl. Acad. Sci. USA 93:10996-11001.
49. Smith, S. A., N. P. Mullin, J. Parkinson, S. N. Shchelkunov, A. V. Totmenin, V. N. Loparev, R. Srisatjaluk, D. N. Reynolds, K. L. Keeling, D. E. Justus, P. N. Barlow, and G. J. Kotwal. 2000. Conserved surface-exposed K/R-X-K/R motifs and net positive charge on poxvirus complement control proteins serve as putative heparin binding sites and contribute to inhibition of molecular interactions with human endothelial cells: a novel mechanism for evasion of host defense. J. Virol. 74:5659-5666.
50. Smith, S. A., R. Sreenivasan, G. Krishnasamy, K. W. Judge, K. H. Murthy, S. J. Arjunwadkar, D. R. Pugh, and G. J. Kotwal. 2003. Mapping of regions within the vaccinia virus complement control protein involved in dose-dependent binding to key complement components and heparin using surface plasmon resonance. Biochim. Biophys. Acta 1650:30-39.
51. Soames, C. J., and R. B. Sim. 1997. Interactions between human complement components factor H, factor I and C3b. Biochem. J. 326:553-561.
52. Stoiber, H., C. Speth, and M. P. Dierich. 2003. Role of complement in the control of HIV dynamics and pathogenesis. Vaccine 21(Suppl. 2):S77-S82.
53. Vanderplasschen, A., E. Mathew, M. Hollinshead, R. B. Sim, and G. L. Smith. 1998. Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope. Proc. Natl. Acad. Sci. USA 95:7544-7549.
54. Volanakis, J. E., and M. M. Frank. 1998. The human complement system in health and disease. Marcel Dekker, Inc., New York, N.Y.
55. Willis, S. H., A. H. Rux, C. Peng, J. C. Whitbeck, A. V. Nicola, H. Lou, W. F. Hou, L. Salvador, R. J. Eisenberg, and G. H. Cohen. 1998. Examination of the kinetics of herpes simplex virus glycoprotein D binding to the herpesvirus entry mediator, using surface plasmon resonance. J. Virol. 72:5937-5947.